Avamed Synergy abre una nueva ronda de financiación de cinco millones de euros. El objetivo es acabar de sufragar las pruebas piloto de su desarrollo Fluxus y adquirir la “fortaleza financiera” a...
The offering, which was structured as straight equity with no warrants attached, attracted strong demand and was significantly oversubscribed. A US-based institutional investor anchored the round with...
España se sitúa como el cuarto país en inversión total en sanidad pública en Europa, con 134 mil millones de euros, superada solo por Alemania (489 mil millones), Francia (313 mil millones) e Ita...
The round was led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg, known for backing 1...
The company previously closed a €650,000 pre-seed round in April 2023 through Capital Cell, complemented by an ENISA participatory loan and NextGeneration-EU grants, reaching a total accumulated fun...
FreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and sol...
The transaction is structured in two tranches: a €2.5 million non-dilutive grant awarded by CDTI under the European Innovation Council (EIC) Seal of Excellence, and the closing of a €500,000 priva...
In the Iberian market, growth has been driven mainly by increased foreign investment inflows. Over the past year, international groups have entered various segments of the value chain, ranging from cl...
Biotasmart is a Lanzadera-accelerated startup that has positioned itself as a benchmark in translating the scientific complexity of the microbiota into personalized clinical recommendations that can b...
The Healthcare sector remains one of the most resilient engines of the European M&A market, despite a 2025 marked by increased macroeconomic uncertainty. According to the Healthcare Update Q4 2025, Sp...
For years, oncology drug launches relied on standardized approaches. But tightening price controls, fiercer competition, and fast-evolving markets are challenging this model. Creating sustainable valu...
The forum Invertir en Ciencia Sí es Rentable has recognized the Galician company Centum and the Catalan biotech ecosystem Biocat for their contribution to the development of innovation in health and ...